potential indications for glp-1 receptor agonists keep expanding Nutritional priorities to support therapy obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society GLP-1 receptor agonists and next-generation

GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise

When calorie intake declines whether through semaglutide , tirzepatide , or other means the body prioritizes energy conservation

S/02/24 and SRF-HF/24)

Check Out Our 5 Star Reviews Additional Services You May Need Medical Weight Loss IV Therapy Body Contouring Morpheus8 Botox Xeomin Dermal Fillers Clearlift Facial Skin Pen Microneedling Facials

Cardiovascular Benefits : Research suggests Ozempic may reduce the risk of heart attacks, strokes, and other cardiovascular events, particularly in those with diabetes

Dont give up if your medication is denied, said Catherine Varney, the obesity medicine director for UVA Health, the health system affiliated with the University of Virginia in Charlottesville